Workshop `Novel Tools for Early Detection of Pancreatic Cancer` 06

page 1 / 2
Workshop 'Novel Tools for Early Detection of Pancreatic Cancer'
06/07 July 2012 at the Hotel Bristol, Bonn, Germany
Preliminary Programme
Friday, 06.07.2012
15.00
Arrivals, Welcome
Session 1: Introduction
15.30 - 16.10
1. Precursor lesions and early pancreatic cancer – what should we look for?
Günter Klöppel, Munich
16.10 - 16.50
2. Tumor microenvironment: impact for early lesion progression
Irene Esposito, München
16.50 - 17.10
Coffee Break
17.10 - 17.30
3. Familial Pancreatic Cancer Screening and Consequences
Detlef Bartsch, Marburg
17.30 - 18.10
4. What do we learn from pancreatic cancer genome sequencing to help the
patient?
N. N.
18.10 - 18.50
5. Cystic Precursor Lesions of Pancreatic Cancer: A paradigm for early
detection of pancreatic neoplasma
Anirban Maitra, Baltimore
19.30
Get Together / Dinner
Saturday, 07.07.2012
09.00
Welcome
Session 2: Biomarker
09.10 - 09.50
6. What (will be) are the requirements for a biomarker to detect early
pancreatic cancer? What are the risk groups amenable for biomarker
screening?
John Neoptolemos, Liverpool
09.50 - 10.30
7. Using molecular markers to improve the accuracy of pancreatic screening
Michael Goggins, Baltimore
10.30 - 10.50
Coffee Break
10.50 - 11.30
8. Is multiplexed serum markers screening the key for early detection of
pancreatic cancer?
Anna E. Lokshin, Pittsburgh
11.30 - 12.10
9. Immune infiltrates as predictive markers in pancreatic cancer
Maria Pia Protti, Milano
12.10 - 13.00
LUNCH
Draft, status: 09.01.2012
page 2 / 2
Session 3: Imaging
13.00 - 13.40
10. Future and presence of molecular imaging
Jan Grimm, New York
13.40 - 14.20
11. New directions in PET imaging
Jason S Lewis, New York
14.20 - 15.00
12. Nature's derived nanoparticles for targeted diagnosis and therapy
William Mulder, New York
15.00 - 15.15
Coffee Break
15.15 - 16.00
Discussion Forum
All speakers and workshop participants
Session 4: Endoscopy
16.00 - 16.20
13. Biomarker discovery in mouse and human pancreatic cancer?
David Tuveson, Cambridge
16.20 - 16.40
14. Fluorescence imaging to detect PanIN lesions
Dieter Saur, Munich
16.40 - 17.00
15. Practical experience with detection of precancerous lesions in high risk
groups in a clinical setting.
Marcia Canto, Baltimore
17.00
Concluding Remarks, Farewells
Draft, status: 09.01.2012